A Registry Study of Percutaneous Coronary Intervention Treatment in Beijing Area of P.R. China

Chinese Academy of Medical Sciences, Fuwai Hospital1 site in 1 country700,000 target enrollmentJanuary 2010

ConditionsCoronary Heart Disease

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Coronary Heart Disease
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital
Enrollment: 700000
Locations: 1
Last Updated: 8 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The registry study is to obtain the state of the art of the percutaneous coronary intervention state treatment for coronary heart disease in Beijing area of P.R.China in a real world. The data are collected from 48 hospitals in Beijing area using an uploading system through internet.

Registry

clinicaltrials.gov

Start Date

January 2010

End Date

December 2020

Last Updated

8 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Chinese Academy of Medical Sciences, Fuwai Hospital

Responsible Party

Principal Investigator

Yuejin Yang

Director of coronary heart disease center, vice president of Fuwai hospital

Chinese Academy of Medical Sciences, Fuwai Hospital

Eligibility Criteria

Inclusion Criteria

•Patients from selected 48 hospitals of Beijing, P.R.China
•Patients receiving coronal artery angiography or percutaneous coronary intervention therapy